Login / Signup

Liquid-phase separations coupled with ion mobility-mass spectrometry for next-generation biopharmaceutical analysis.

Devin M MakeyBrandon T Ruotolo
Published in: Expert review of proteomics (2024)
IM-MS has the potential to enhance the depth and efficiency of biotherapeutic characterization by providing additional insights into conformational changes, post-translational modifications, and impurity profiles. The rapid timescale of IM-MS positions it well to enhance the information content of existing assays through its facile integration with standard liquid-phase separation techniques that are commonly used for biopharmaceutical analysis.
Keyphrases
  • mass spectrometry
  • multiple sclerosis
  • ms ms
  • healthcare
  • high throughput
  • molecular dynamics
  • single molecule
  • quantum dots
  • high performance liquid chromatography
  • health information
  • reduced graphene oxide